Shows galectin-9 alters th1/th2 balance in asthma, indicating it may be a treatment option.
Inhibition of Gal-9 restores Th1/Th2 balance and reduces inflammation in BA, suggesting Gal-9 as a potential therapeutic target for asthma treatment.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: